Published in Science on October 14, 1949
Plasma and red cell iron turnover in normal subjects and in patients having various hematopoietic disorders. J Clin Invest (1950) 6.62
The destruction of red cells by antibodies in man. I. Observations of the sequestration and lysis of red cells altered by immune mechanisms. J Clin Invest (1957) 4.37
The distribution of Fe59 tagged human erythrocytes in centrifuged specimens as a function of cell age. J Clin Invest (1957) 2.89
The plasma-to-cell cycle of transferrin. J Clin Invest (1963) 2.59
Haemoglobin formation in rabbits. J Physiol (1951) 2.24
Transfer of iron from serum iron-binding protein to human reticulocytes. J Clin Invest (1959) 2.22
The quantitative determination of iron kinetics and hemoglobin synthesis in human subjects. J Clin Invest (1961) 2.07
Relationship between the age of human erythrocytes and their osmotic resistance: a basis for separating young and old erythrocytes. J Clin Invest (1958) 1.85
The incidence and significance of iron-containing granules in human erythrocytes and their precursors. J Clin Pathol (1953) 1.45
The long history of iron in the Universe and in health and disease. Biochim Biophys Acta (2011) 1.33
The oxygen consumption of the blood in experimental lead poisoning. Br J Exp Pathol (1954) 1.26
Loss of the transferrin receptor during the maturation of sheep reticulocytes in vitro. An immunological approach. Biochem J (1983) 1.16
Induction of alered globin synthesis in human immature erythrocytes incubated with ribonucleoprotein. Proc Natl Acad Sci U S A (1962) 1.04
Studies on the biochemical defect of pernicious anemia. I. In vitro observations on oxygen consumption, heme synthesis and deoxyribonucleic acid synthesis by pernicious anemia bone marrow. J Clin Invest (1958) 1.00
Observations on the centrifugal segregation of young erythrocytes: a possible method of genotyping the transfused patient. J Clin Pathol (1959) 0.96
An intracellular protein intermediate for hemoglobin formation. J Clin Invest (1962) 0.90
Macrophages and iron trafficking at the birth and death of red cells. Blood (2015) 0.89
Studies on the partition of iron in bone marrow cells. J Clin Invest (1968) 0.85
STUDIES ON THE FORMATION OF FERRITIN IN RED CELL PRECURSORS. J Clin Invest (1964) 0.85
Biosynthesis of the transferrin receptor in rabbit reticulocytes. J Clin Invest (1985) 0.79
THE TRANSFER OF IRON TO RETICULOCYTES BY SYNTHETIC CHELATING AGENTS. J Clin Invest (1964) 0.75
What's new in isotopes, 1950. Calif Med (1950) 0.75
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation (1974) 10.91
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med (1995) 10.04
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med (1980) 9.64
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXVIII. SERUM IRON TRANSPORT. MEASUREMENT OF IRON-BINDING CAPACITY OF SERUM IN MAN. J Clin Invest (1949) 7.00
THE IN VITRO PRESERVATION AND POST-TRANSFUSION SURVIVAL OF STORED BLOOD. J Clin Invest (1947) 4.45
Bone-marrow transplantation (second of two parts). N Engl J Med (1975) 4.11
A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet (1979) 4.01
A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med (1974) 3.92
Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med (1979) 3.59
Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis (1986) 3.31
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood (1981) 3.03
Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc (1974) 2.95
Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med (1981) 2.61
The physiology of transferrin and transferrin receptors. Physiol Rev (1987) 2.60
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis (1983) 2.39
One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood (1977) 2.36
Effect of altitude on oxygen binding by hemoglobin and on organic phosphate levels. J Clin Invest (1968) 2.35
Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood (1976) 2.29
Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol (1988) 2.24
Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 2.23
Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology (1984) 2.19
Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma. Lancet (1972) 2.13
A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis (1977) 2.10
Ferrokinetics in man. Medicine (Baltimore) (1970) 2.08
Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr (1974) 2.06
Oxygen transport in man. N Engl J Med (1972) 2.05
Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature (1987) 2.04
Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Intern Med (1983) 2.03
Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med (1986) 1.99
Thrombokinetics in man. J Clin Invest (1969) 1.99
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood (1994) 1.98
Evaluation of the iron status of a population. Blood (1976) 1.94
Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med (1979) 1.94
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol (1990) 1.91
Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med (1983) 1.89
The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: a prospective study of thirteen patients. Gastroenterology (1980) 1.88
A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood (1979) 1.83
Technique for human marrow grafting. Blood (1970) 1.83
Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80
Leukaemic transformation of engrafted human marrow cells in vivo. Lancet (1971) 1.79
Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med (1988) 1.77
Perspectives in iron metabolism. N Engl J Med (1982) 1.77
Allogeneic marrow grafting for treatment of aplastic anemia. Blood (1974) 1.76
Effect of blood donation on iron stores as evaluated by serum ferritin. Blood (1977) 1.74
Bone marrow grafts and tolerance. Nature (1986) 1.74
Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol (1988) 1.72
Neutrophil kinetics in man. J Clin Invest (1976) 1.72
Marrow transplantation for thalassaemia. Lancet (1982) 1.71
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood (1997) 1.64
Blood ferrokinetics in normal man. J Clin Invest (1967) 1.64
Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas. Blood (1987) 1.63
Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet (1984) 1.60
Myocardial necrosis from direct current countershock. Effect of paddle electrode size and time interval between discharges. Circulation (1974) 1.58
The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol (1977) 1.58
Hemophilia: role of organ homografts. Science (1969) 1.56
Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury. N Engl J Med (1981) 1.56
Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol (1979) 1.55
Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex. N Engl J Med (1977) 1.55
Differences between the binding sites for iron binding and release in human and rat transferrin. Blood (1978) 1.50
Intraerythrocytic adaptation to anemia. N Engl J Med (1970) 1.49
Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation (1973) 1.48
Estimation of available dietary iron. Am J Clin Nutr (1978) 1.48
Practical considerations in using counterimmunoelectrophoresis to identify the principal causative agents of bacterial meningitis. J Clin Microbiol (1979) 1.47
Acute hepatic coma treated by cross-circulation or exchange transfusion. N Engl J Med (1967) 1.46
Bone marrow transplantation in acute leukemia. Cancer Res (1965) 1.46
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med (1983) 1.44
Rapid diagnosis of cytomegaloviral pneumonia by tissue immunofluorescence with a murine monoclonal antibody. J Infect Dis (1985) 1.44
Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med (1979) 1.44
Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med (1967) 1.41
Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med (1986) 1.41
Effect of induced fever on serum iron and ferritin concentrations in man. Blood (1977) 1.41
Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. Bone Marrow Transplant (1992) 1.40
The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis (1979) 1.40
T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood (1982) 1.39
Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood (1988) 1.39
The kidney and erythropoiesis. Am J Med (1968) 1.39
Aplastic anaemia treated by marrow transplantation. Lancet (1972) 1.39
Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood (1990) 1.39
Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med (1982) 1.38
The Tessier number 9 cleft. Plast Reconstr Surg (1989) 1.38
Storage iron kinetics. VII. A biologic model for reticuloendothelial iron transport. J Clin Invest (1974) 1.38
Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation (1970) 1.37
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood (1993) 1.36
BLOOD PLASMA PROTEIN PRODUCTION AND UTILIZATION : THE INFLUENCE OF AMINO ACIDS AND OF STERILE ABSCESSES. J Exp Med (1940) 1.36
Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. Int J Cancer (1991) 1.36
Use of a probe to repeat sequence of the Y chromosome for detection of host cells in peripheral blood of bone marrow transplant recipients. Am J Clin Pathol (1991) 1.35
Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. J Clin Invest (1976) 1.35
Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature (1982) 1.35
Plasma ferritin determination as a diagnostic tool. West J Med (1986) 1.34
Allogeneic bone-marrow transplantation. Immunol Rev (1983) 1.34
Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation. Transplantation (1985) 1.34
Storage iron kinetics. VI. The effect of inflammation on iron exchange in the rat. Br J Haematol (1974) 1.33
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy. J Clin Oncol (1989) 1.33
Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med (1977) 1.31